...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith got a licensing upgrade.

Good point Koo...they need to pay back RVX....at least Zenith is still alive.

Share
New Message
Please login to post a reply